Expression and subcellular localization of USH1C/harmonin in human retina provides insights into pathomechanisms and therapy. Issue 3 (23rd August 2022)

• Record Type: Journal Article
• Authors: Nagel-Wolfrum, Kerstin; Fadl, Benjamin R; Becker, Mirjana M; Wunderlich, Kirsten A; Schäfer, Jessica; Sturm, Daniel; Fritze, Jacques; Gür, Burcu; Kaplan, Lew; Andreani, Tommaso; Goldmann, Tobias; Brooks, Matthew; Starostik, Margaret R; Lokhande, Anagha; Apel, Melissa; Fath, Karl R; Stingl, Katarina; Kohl, Susanne; DeAngelis, Margaret M; Schlötzer-Schrehardt, Ursula; Kim, Ivana K; Owen, Leah A; Vetter, Jan M; Pfeiffer, Norbert; Andrade-Navarro, Miguel A; Grosche, Antje; Swaroop, Anand; Wolfrum, Uwe
• Is Part Of: Human molecular genetics. Volume 32:Issue 3(2023)
• Page Start: 431
• Page End: 449
• Publication Date: 2022-08-23
• Subjects: Human molecular genetics -- Periodicals; Human chromosome abnormalities -- Periodicals; 572.8
• DOI: 10.1093/hmg/ddac211
• Languages: English
• ISSNs: 0964-6906

Abstract

Abstract: Usher syndrome (USH) is the most common form of hereditary deaf-blindness in humans. USH is a complex genetic disorder, assigned to three clinical subtypes differing in onset, course and severity, with USH1 being the most severe. Rodent USH1 models do not reflect the ocular phenotype observed in human patients to date; hence, little is known about the pathophysiology of USH1 in the human eye. One of the USH1 genes, USH1C, exhibits extensive alternative splicing and encodes numerous harmonin protein isoforms that function as scaffolds for organizing the USH interactome. RNA-seq analysis of human retinae uncovered harmonin_a1 as the most abundant transcript of USH1C . Bulk RNA-seq analysis and immunoblotting showed abundant expression of harmonin in Müller glia cells (MGCs) and retinal neurons. Furthermore, harmonin was localized in the terminal endfeet and apical microvilli of MGCs, presynaptic region (pedicle) of cones and outer segments (OS) of rods as well as at adhesive junctions between MGCs and photoreceptor cells (PRCs) in the outer limiting membrane (OLM). Our data provide evidence for the interaction of harmonin with OLM molecules in PRCs and MGCs and rhodopsin in PRCs. Subcellular expression and colocalization of harmonin correlate with the clinical phenotype observed in USH1C patients. We also demonstrate that primary cilia defects in USH1C patient-derived fibroblasts could be reverted by the delivery of harmonin_a1 transcript isoform. Our studies thus provide novel insights into PRC cell biology, USH1C pathophysiology and development of gene therapy treatment(s).